Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04513639
Title The Relapse From MRD Negativity as Indication for Treatment (REMNANT) Study
Acronym REMNANT
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oslo University Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Haukeland University Hospital RECRUITING Bergen Norway Details
Nordland Hospital Bodø RECRUITING Bodø Norway Details
Sykehuset Ostfold RECRUITING Fredrikstad Norway Details
Førde Central Hospital RECRUITING Førde Norway Details
Sørlandet Hospital Kristiansand RECRUITING Kristiansand Norway Details
Levanger Hospital RECRUITING Levanger Norway Details
Akershus University Hospital RECRUITING Lørenskog Norway Details
Oslo University Hospital RECRUITING Oslo Norway Details
Helse Stavanger HF RECRUITING Stavanger Norway Details
University Hospital North Norway RECRUITING Tromsø Norway Details
St. Olavs Hospital RECRUITING Trondheim Norway Details
The Hospital of Vestfold RECRUITING Tønsberg Norway Details
Ålesund Hospital RECRUITING Ålesund Norway Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field